# Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

> **NCT05681182** · PHASE4 · COMPLETED · sponsor: **WakeMed Health and Hospitals** · enrollment: 30 (actual)

## Conditions studied

- Post Operative Atrial Fibrillation

## Interventions

- **COMBINATION_PRODUCT:** CardiaMend with the Addition of Amiodarone

## Key facts

- **NCT ID:** NCT05681182
- **Lead sponsor:** WakeMed Health and Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-20
- **Primary completion:** 2024-02-06
- **Final completion:** 2024-02-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05681182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05681182, "Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05681182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*